NCT07171905
- Conditions
- Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +9 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, Italia, Italy
Clinical trial condition
VHL - Von Hippel-Lindau Syndrome
Explore clinical trials studying VHL - Von Hippel-Lindau Syndrome. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
VHL - Von Hippel-Lindau Syndrome trial results
Not Yet Recruiting
Belzutifan VHL RCC HK Prospective Registry
NCT07554508
- Conditions
- Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +9 more
- Locations
-
- Prince of Wales Hospital Shatin, Hong Kong
Active, Not Recruiting
Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau Syndrome.
NCT07275099
- Conditions
- Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +9 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy
Active, Not Recruiting
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)
NCT03401788
- Conditions
- Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- University of Michigan Ann Arbor, Michigan, United States
- University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States